Enhabit

EHAB

Market cap $689M

PHILADELPHIA, March 05, 2026 (GLOBE NEWSWIRE) -- Kaskela Law LLC has launched an investigation into the fairness of the recently announced proposed buyout of Enhabit, Inc. (NYSE: EHAB) shareholders to determine whether the $13.80 per share buyout price undervalues the company's shares.  Click here to request additional information:  https://kaskelalaw.com/case/enhabit/ On February 23, 2026, Enhabit announced that it had agreed to be acquired by private equity firm Kinderhook Industries at a price of $13.80 per share in cash.

Enhabit (EHAB) came out with quarterly earnings of $0.14 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.04 per share a year ago.

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended Dec. 31, 2025. “Our fourth quarter 2025 results capped a pivotal year for Enhabit, delivering an emerging growth story with year over year increases in patient census, revenue and Adjusted EBITDA,” said Barb Jacobsmeyer, CEO and president of Enhabit. “The consistent execution of our strategy throughout the year materially imp.

Enhabit (EHAB) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

NEW YORK, Feb. 24, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Enhabit Inc. (NYSE: EHAB) related to its sale to Kinderhook Industries, LLC.

Bala Cynwyd, Pennsylvania--(Newsfile Corp. - February 24, 2026) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Enhabit, Inc. ("Enhabit" or the "Company") (NYSE: EHAB) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Kinderhook Industries, LLC ("Kinderhook") for $13.80 a share in an all-cash transaction for a total enterprise value of approximately $1.1 billion. The investigation concerns whether the Enhabit Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company's shareholders.

Enhabit (EHAB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Enhabit, Inc. (NYSE: EHAB) to Kinderhook Industries, LLC. Under the terms of the proposed transaction, shareholders of Enhabit will receive $13.80 per share in cash. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration under.

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Enhabit, Inc. (NYSE: EHAB) to Kinderhook Industries, LLC for $13.80 per share in cash. Halper Sadeh encourages Enhabit shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whether Enhabit and its board of directors violate.

MILWAUKEE, Feb. 23, 2026 /PRNewswire/ -- Ademi LLP is investigating Enhabit (NYSE: EHAB) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Kinderhook Industries. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995.